Besides having a heavy hand in advancing the field of genomic medicines and solidifying the foundation for what has become the bustling I-270 Biotech Corridor, it’s clear that HGS has also had a major impact on the lives of those who worked there. BioBuzz in collaboration with Kymanox and BioIT Solutions recently hosted a HGS reunion event at True Respite Brewing Co., bringing together over 140 alumni of the organization. Some attendees even came in from out of state to catch up with former colleagues and friends that they haven’t seen in years.
The seas have been rough this year for the biotech and life sciences market, with funding scarcity and layoffs abound. The BioHealth Capital Region (BHCR) has braced the storm, though, holding tight to its fourth-place ranking on the Genetic & Engineering News (GEN) Top 10 Biopharma Clusters list. Alex Phillipidus, Senior Business Editor for GEN, gave the update at the eighth annual BioHealth Capital Region Forum.
Gaithersburg-based Neuroene Therapeutics and its approach to treating a rare form of epilepsy was crowned the winner of the seventh annual Crab Trap Competition, which highlights the commercialization potential of biohealth technologies throughout the BioHealth Capital Region.
Sometimes a new set of eyes on your job search strategy or promotion approach can make all the difference in the world. Engaging a career coach or consultant is a great way to enhance what you’re already doing right and learn new techniques to get more from your networking and professional development activities. For employers looking to retain their key talent, providing coaching opportunities is also beneficial, as it shows your organization believes in them, is willing to invest in their future, and cares about their success.
William McPheat, one of the Life Science Mentors associated with the Innovation Commercialization Assistance Program (ICAP) at George Mason University explained that drug developers need to have an understanding of the future market long before a drug is ever approved by the U.S. Food and Drug Administration. McPheat, who spent more than 25 year with AstraZeneca, said that was something the pharma giant had to explore when planning development programs. And, he said it’s also critical for startups that may be looking to be acquired by a larger company before getting too deep into the clinical process.
In response to the COVID-19 pandemic, AGT™ CEO Jeff Galvin decided to turn “lemons into lemonade” by creating a COVID-19 testing lab. This new testing lab provided security for the in-person staff running experiments in the company’s research lab while also generating more than $10M in funding for its HIV cure program.
n 2020 and 2021 (and, to some degree, continuing today) all processes were dramatically impacted by the pandemic as many employees, consultants, and others were restricted from physically working in the office or manufacturing facility, resulting in skeleton crews and largely remote workers. Critical processes throughout the development lifecycle of pharmaceutical, biotech, and medical device products were required to transition from in-person to virtual procedures and processes.
The rapidly growing Philadelphia life sciences sector is hungry for lab and manufacturing space. Real estate developers are meeting that demand with ambitious projects to build, rebuild, and overbuild sites to produce facilities that will retain and attract life sciences companies.
Launched in 2019, Deka is the first cytokine-based biotech company to call the BioHealth Capital Region home. In less than a year, Deka has tripled in size and has consistently hit milestones that have expanded its capabilities, fostered growth, and advanced its promising pipeline. The company’s recent string of successes have been underpinned by innovative science propelled by top-notch scientists.
Malone is the Managing Director of Early Charm and the CEO of SilcsBio, one of the 37 portfolio companies that operate under Early Charm’s novel Venture Studio Model. We recently caught up with Malone to discuss a wide range of topics, including the Venture Studio Model, SilcsBio, and the growing life sciences and technology ecosystem blooming in Baltimore.